CeloNova Biosciences, Inc. develops and manufactures medical devices. It offers Embozene color-advanced microspheres, a spherical embolic device for the treatment of neurovascular arteriovenous malformations, uterine fibroids, hepatocellular carcinoma, hypervascularized tumors, and arteriovenous malformations; and CATANIA coronary stent systems for symptomatic ischemic heart disease due to de novo and obstructive lesions of native coronary arteries. The company offers its products through distributors in Austria, Belgium, Luxembourg, Germany, Ireland, Israel, Italy, Poland, Spain, Switzerland, Turkey, and the United Kingdom.